General Information of the Protein
Protein ID
PT06635
Protein Name
Toxin A
Gene Name
TCDA
Secondarily
Gene Name
toxA
Sequence
MSLISKEELIKLAYSIRPRENEYKTILTNLDEYNKLTTNNNENKYLQLKKLNESIDVFMNKYKTSSRNRALSNLKKDILKEVILIKNSNTSPVEKNLHFVWIGGEVSDIALEYIKQWADINAEYNIKLWYDSEAFLVNTLKKAIVESSTTEALQLLEEEIQNPQFDNMKFYKKRMEFIYDRQKRFINYYKSQINKPTVPTIDDIIKSHLVSEYNRDETVLESYRTNSLRKINSNHGIDIRANSLFTEQELLNIYSQELLNRGNLAAASDIVRLLALKNFGGVYLDVDMLPGIHSDLFKTISRPSSIGLDRWEMIKLEAIMKYKKYINNYTSENFDKLDQQLKDNFKLIIESKSEKSEIFSKLENLNVSDLEIKIAFALGSVINQALISKQGSYLTNLVIEQVKNRYQFLNQHLNPAIESDNNFTDTTKIFHDSLFNSATAENSMFLTKIAPYLQVGFMPEARSTISLSGPGAYASAYYDFINLQENTIEKTLKASDLIEFKFPENNLSQLTEQEINSLWSFDQASAKYQFEKYVRDYTGGSLSEDNGVDFNKNTALDKNYLLNNKIPSNNVEEAGSKNYVHYIIQLQGDDISYEATCNLFSKNPKNSIIIQRNMNESAKSYFLSDDGESILELNKYRIPERLKNKEKVKVTFIGHGKDEFNTSEFARLSVDSLSNEISSFLDTIKLDISPKNVEVNLLGCNMFSYDFNVEETYPGKLLLSIMDKITSTLPDVNKNSITIGANQYEVRINSEGRKELLAHSGKWINKEEAIMSDLSSKEYIFFDSIDNKLKAKSKNIPGLASISEDIKTLLLDASVSPDTKFILNNLKLNIESSIGDYIYYEKLEPVKNIIHNSIDDLIDEFNLLENVSDELYELKKLNNLDEKYLISFEDISKNNSTYSVRFINKSNGESVYVETEKEIFSKYSEHITKEISTIKNSIITDVNGNLLDNIQLDHTSQVNTLNAAFFIQSLIDYSSNKDVLNDLSTSVKVQLYAQLFSTGLNTIYDSIQLVNLISNAVNDTINVLPTITEGIPIVSTILDGINLGAAIKELLDEHDPLLKKELEAKVGVLAINMSLSIAATVASIVGIGAEVTIFLLPIAGISAGIPSLVNNELILHDKATSVVNYFNHLSESKKYGPLKTEDDKILVPIDDLVISEIDFNNNSIKLGTCNILAMEGGSGHTVTGNIDHFFSSPSISSHIPSLSIYSAIGIETENLDFSKKIMMLPNAPSRVFWWETGAVPGLRSLENDGTRLLDSIRDLYPGKFYWRFYAFFDYAITTLKPVYEDTNIKIKLDKDTRNFIMPTITTNEIRNKLSYSFDGAGGTYSLLLSSYPISTNINLSKDDLWIFNIDNEVREISIENGTIKKGKLIKDVLSKIDINKNKLIIGNQTIDFSGDIDNKDRYIFLTCELDDKISLIIEINLVAKSYSLLLSGDKNYLISNLSNTIEKINTLGLDSKNIAYNYTDESNNKYFGAISKTSQKSIIHYKKDSKNILEFYNDSTLEFNSKDFIAEDINVFMKDDINTITGKYYVDNNTDKSIDFSISLVSKNQVKVNGLYLNESVYSSYLDFVKNSDGHHNTSNFMNLFLDNISFWKLFGFENINFVIDKYFTLVGKTNLGYVEFICDNNKNIDIYFGEWKTSSSKSTIFSGNGRNVVVEPIYNPDTGEDISTSLDFSYEPLYGIDRYINKVLIAPDLYTSLININTNYYSNEYYPEIIVLNPNTFHKKVNINLDSSSFEYKWSTEGSDFILVRYLEESNKKILQKIRIKGILSNTQSFNKMSIDFKDIKKLSLGYIMSNFKSFNSENELDRDHLGFKIIDNKTYYYDEDSKLVKGLININNSLFYFDPIEFNLVTGWQTINGKKYYFDINTGAALTSYKIINGKHFYFNNDGVMQLGVFKGPDGFEYFAPANTQNNNIEGQAIVYQSKFLTLNGKKYYFDNNSKAVTGWRIINNEKYYFNPNNAIAAVGLQVIDNNKYYFNPDTAIISKGWQTVNGSRYYFDTDTAIAFNGYKTIDGKHFYFDSDCVVKIGVFSTSNGFEYFAPANTYNNNIEGQAIVYQSKFLTLNGKKYYFDNNSKAVTGLQTIDSKKYYFNTNTAEAATGWQTIDGKKYYFNTNTAEAATGWQTIDGKKYYFNTNTAIASTGYTIINGKHFYFNTDGIMQIGVFKGPNGFEYFAPANTDANNIEGQAILYQNEFLTLNGKKYYFGSDSKAVTGWRIINNKKYYFNPNNAIAAIHLCTINNDKYYFSYDGILQNGYITIERNNFYFDANNESKMVTGVFKGPNGFEYFAPANTHNNNIEGQAIVYQNKFLTLNGKKYYFDNDSKAVTGWQTIDGKKYYFNLNTAEAATGWQTIDGKKYYFNLNTAEAATGWQTIDGKKYYFNTNTFIASTGYTSINGKHFYFNTDGIMQIGVFKGPNGFEYFAPANTDANNIEGQAILYQNKFLTLNGKKYYFGSDSKAVTGLRTIDGKKYYFNTNTAVAVTGWQTINGKKYYFNTNTSIASTGYTIISGKHFYFNTDGIMQIGVFKGPDGFEYFAPANTDANNIEGQAIRYQNRFLYLHDNIYYFGNNSKAATGWVTIDGNRYYFEPNTAMGANGYKTIDNKNFYFRNGLPQIGVFKGSNGFEYFAPANTDANNIEGQAIRYQNRFLHLLGKIYYFGNNSKAVTGWQTINGKVYYFMPDTAMAAAGGLFEIDGVIYFFGVDGVKAPGIYG
    Show/Hide
Organism
Clostridioides difficile, Peptoclostridium difficile
Protein Classification
Enzyme
>
Hydrolase
Function
Precursor of a cytotoxin that targets and disrupts the colonic epithelium, inducing the host inflammatory and innate immune responses and resulting in diarrhea and pseudomembranous colitis (PubMed:20844489). TcdA and TcdB constitute the main toxins that mediate the pathology of C.difficile infection, an opportunistic pathogen that colonizes the colon when the normal gut microbiome is disrupted (PubMed:19252482, PubMed:20844489). Compared to TcdB, TcdA is less virulent and less important for inducing the host inflammatory and innate immune responses (PubMed:19252482). This form constitutes the precursor of the toxin: it enters into host cells and mediates autoprocessing to release the active toxin (Glucosyltransferase TcdA) into the host cytosol (By similarity). Targets colonic epithelia by binding to some receptor, and enters host cells via clathrin-mediated endocytosis (By similarity). Binding to LDLR, as well as carbohydrates and sulfated glycosaminoglycans on host cell surface contribute to entry into cells (PubMed:1670930, PubMed:31160825, PubMed:16622409). In contrast to TcdB, Frizzled receptors FZD1, FZD2 and FZD7 do not act as host receptors in the colonic epithelium for TcdA (PubMed:27680706). Once entered into host cells, acidification in the endosome promotes the membrane insertion of the translocation region and formation of a pore, leading to translocation of the GT44 and peptidase C80 domains across the endosomal membrane (By similarity). This activates the peptidase C80 domain and autocatalytic processing, releasing the N-terminal part (Glucosyltransferase TcdA), which constitutes the active part of the toxin, in the cytosol (PubMed:17334356, PubMed:19553670, PubMed:27571750).
    Show/Hide
Uniprot ID
Primary ID:
P16154

Secondarily ID:
M4NKU2
    Show/Hide
Subcellular Location
Secreted
Host endosome membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0469329
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methoxypyridin-2-yl)-2-methylbenzamide
   Show/Hide
C30H26ClN5O4
 1
1
IC50 = 480 nM
   TI
   LI
   LO
   TS
CP0323280
2-chloro-4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methylpyridin-2-yl)benzamide
   Show/Hide
C29H23Cl2N5O3
 1
1
IC50 = 580 nM
   TI
   LI
   LO
   TS
CP0517646
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methoxypyrimidin-2-yl)-2-methylbenzamide
   Show/Hide
C29H25ClN6O4
 1
1
IC50 = 690 nM
   TI
   LI
   LO
   TS
CP0334651
2-chloro-4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methoxypyridin-2-yl)benzamide
   Show/Hide
C29H23Cl2N5O4
 1
1
IC50 = 760 nM
   TI
   LI
   LO
   TS
CP0366069
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-2-methyl-N-(5-methylpyridin-2-yl)benzamide
   Show/Hide
C30H26ClN5O3
 1
1
IC50 = 860 nM
   TI
   LI
   LO
   TS
CP0558003
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-fluoropyridin-2-yl)-2-methylbenzamide
   Show/Hide
C29H23ClFN5O3
 1
1
IC50 = 860 nM
   TI
   LI
   LO
   TS
CP0436015
2-chloro-4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methoxypyrimidin-2-yl)benzamide
   Show/Hide
C28H22Cl2N6O4
 1
1
IC50 = 920 nM
   TI
   LI
   LO
   TS
CP0536850
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methoxypyridin-2-yl)benzamide
   Show/Hide
C29H24ClN5O4
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0459069
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-2-methoxy-N-(5-methoxypyridin-2-yl)benzamide
   Show/Hide
C30H26ClN5O5
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0222526
2-chloro-4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methylpyrimidin-2-yl)benzamide
   Show/Hide
C28H22Cl2N6O3
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0436014
2-chloro-4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-fluoropyridin-2-yl)benzamide
   Show/Hide
C28H20Cl2FN5O3
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0517639
2-chloro-4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methylpyrazin-2-yl)benzamide
   Show/Hide
C28H22Cl2N6O3
 1
1
IC50 = 2100 nM
   TI
   LI
   LO
   TS
CP0537912
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-2-methyl-N-[5-(trifluoromethyl)pyridin-2-yl]benzamide
   Show/Hide
C30H23ClF3N5O3
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0450807
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methoxypyrimidin-2-yl)benzamide
   Show/Hide
C28H23ClN6O4
 1
1
IC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0160362
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-2-methyl-N-(5-methylpyrimidin-2-yl)benzamide
   Show/Hide
C29H25ClN6O3
 1
1
IC50 = 3000 nM
   TI
   LI
   LO
   TS
CP0404225
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methylpyridin-2-yl)benzamide
   Show/Hide
C29H24ClN5O3
 1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CP0467677
2-chloro-4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-methoxypyrazin-2-yl)benzamide
   Show/Hide
C28H22Cl2N6O4
 1
1
IC50 = 3400 nM
   TI
   LI
   LO
   TS
CP0517648
(3R)-8-chloro-4-[[4-(1-methylpyrrolo[3,2-b]pyridine-3-carbonyl)phenyl]methyl]-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepine-2,5-dione
   Show/Hide
C31H24ClN5O3
 1
1
IC50 = 5300 nM
   TI
   LI
   LO
   TS
CP0557317
2-chloro-4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-[5-(trifluoromethyl)pyridin-2-yl]benzamide
   Show/Hide
C29H20Cl2F3N5O3
 1
1
IC50 = 6300 nM
   TI
   LI
   LO
   TS
CP0436013
(3R)-8-chloro-4-[[4-(imidazo[1,2-a]pyridine-8-carbonyl)phenyl]methyl]-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepine-2,5-dione
   Show/Hide
C30H22ClN5O3
 1
1
IC50 = 8100 nM
   TI
   LI
   LO
   TS
CP0436012
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-2-methoxy-N-(5-methylpyridin-2-yl)benzamide
   Show/Hide
C30H26ClN5O4
 1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0210833
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-N-(5-fluoropyridin-2-yl)-2-methoxybenzamide
   Show/Hide
C29H23ClFN5O4
 1
1
IC50 = 17000 nM
   TI
   LI
   LO
   TS
CP0147046
(3R)-8-chloro-3-(pyridin-2-ylmethyl)-4-[[4-(1H-pyrrolo[3,2-b]pyridine-3-carbonyl)phenyl]methyl]-1,3-dihydro-1,4-benzodiazepine-2,5-dione
   Show/Hide
C30H22ClN5O3
 1
1
IC50 = 18000 nM
   TI
   LI
   LO
   TS
CP0532436
(3R)-8-chloro-4-[[4-(5-methylpyridine-2-carbonyl)phenyl]methyl]-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepine-2,5-dione
   Show/Hide
C29H23ClN4O3
 1
1
IC50 = 23000 nM
   TI
   LI
   LO
   TS
CP0436016
4-[[(3R)-8-chloro-2,5-dioxo-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-4-yl]methyl]-2-methoxy-N-[5-(trifluoromethyl)pyridin-2-yl]benzamide
   Show/Hide
C30H23ClF3N5O4
 1
1
IC50 = 31000 nM
   TI
   LI
   LO
   TS
CP0160363
(3R)-8-chloro-4-[[4-(pyridine-2-carbonyl)phenyl]methyl]-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepine-2,5-dione
   Show/Hide
C28H21ClN4O3
 1
1
IC50 = 37000 nM
   TI
   LI
   LO
   TS
CP0459070
(3R)-8-chloro-4-[[4-(1-methylimidazole-4-carbonyl)phenyl]methyl]-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepine-2,5-dione
   Show/Hide
C27H22ClN5O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0558033
(3R)-8-chloro-4-[[4-(1-methylimidazole-2-carbonyl)phenyl]methyl]-3-(pyridin-2-ylmethyl)-1,3-dihydro-1,4-benzodiazepine-2,5-dione
   Show/Hide
C27H22ClN5O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Clostridium difficile Toxin A (CD toxA) )
Target Type Clinical trial Target